Additionally, this work confirms the previous findings of our group in HIV/HCV-coinfected patients [34]; suggesting that CXCL9-11 polymorphisms may play a key role in the development of liver fibrosis during CHC. This evidence concerns the gene CXCL9 and Hepatic fibrosis.